Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 03-2017 | 12-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,377 | 0 | -17,453 | 0 | N/A |
| Depreciation Amortization | 1,480 | 320 | 808 | 0 | N/A |
| Accounts payable and accrued liabilities | 285 | 0 | 1,800 | 0 | N/A |
| Other Working Capital | 26,729 | 5,220 | 58,567 | 0 | N/A |
| Other Operating Activity | 4,461 | -400 | -2,309 | 0 | 0 |
| Operating Cash Flow | $-12,422 | $5,140 | $41,413 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,973 | -1,090 | -836 | 0 | N/A |
| Purchase Of Investment | 0 | 0 | -97,048 | 0 | N/A |
| Sale Of Investment | 27,891 | 0 | 28,916 | 0 | N/A |
| Other Investing Activity | 0 | 14,590 | 0 | 0 | 0 |
| Investing Cash Flow | $25,918 | $13,500 | $-68,968 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 102 | 0 | 4 | 0 | N/A |
| Other Financing Activity | -1,138 | 0 | 25,938 | 0 | 0 |
| Financing Cash Flow | $-1,036 | $0 | $25,942 | $0 | $N/A |
| Beginning Cash Position | 11,080 | 0 | 12,693 | 0 | N/A |
| End Cash Position | 23,540 | 0 | 11,080 | 0 | N/A |
| Net Cash Flow | $12,460 | $18,640 | $-1,613 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,422 | 5,140 | 41,413 | 0 | N/A |
| Capital Expenditure | -1,973 | 0 | -836 | 0 | N/A |
| Free Cash Flow | -14,395 | 5,140 | 40,577 | 0 | 0 |